Literature DB >> 170377

Cyclic AMP potentiation of interferon antiviral activity and effect of interferon on cellular cyclic AMP levels.

J M Weber, R B Stewart.   

Abstract

Treatment of L cells with 3 to 10 mM 3':5'-cyclic adenosine monophosphate (cAMP) in the presence of interferon was found to potentiate the development of antiviral activity. The dose response of interferon activity at various time periods in the presence and absence of cAMP indicated that potentiation of interferon activity by cAMP occurred at an early stage in the development of antiviral activity. Among the analogues of cAMP tested for interferon-potentiating activity, only the acylated derivatives were found to be active. Combined L-epinephrine and theophylline treatment of cells elevated cellular cAMP levels and also potentiated interferon-mediated antiviral activity. Interferon was also found to elevate cAMP levels in L cells. This activity was limited to biologically active interferon and antagonized the depression of cAMP associated with vesicular stomatitis virus (VSV) infection of L cells. These observations suggest that some aspects of interferon's biological activity is associated with an alteration in cellular levels of cAMP.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170377     DOI: 10.1099/0022-1317-28-3-363

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Effect of cholera toxin on the antiviral and anticellular activities of human leukocyte interferon.

Authors:  A Fuse; T Kuwata
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

2.  Modulation of lymphoid cell sensitivity to interferon by thyroid hormones.

Authors:  M Provinciali; N Fabris
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

3.  Interferon inhibition of lymphocyte mitogenesis.

Authors:  Y Weinstein; B R Brodeur; K L Melmon; T C Merigan
Journal:  Immunology       Date:  1977-09       Impact factor: 7.397

4.  Interferon production and activity in mouse neuroblastoma cells.

Authors:  S A Stohlman; A Y Sakaguchi; A Hiti
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

5.  Modulation of immune responses in newborn and adult mice by interferon.

Authors:  O Strannegård; I Larsson; E Lundgren; H Miörner; H Persson
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

Review 6.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Cyclic AMP-dependent regulation of activities of synthetase and phosphodiesterase of 2',5'-oligoadenylate in NIH 3T3 cells.

Authors:  A V Itkes; K T Turpaev; O N Kartasheva; C A Kafiani; E S Severin
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

8.  [Intracellular cyclic AMP in vesicular stomatitis or Sendaï virus infected cells (author's transl)].

Authors:  P Vallier; J Farjanel; J Bata; P Deviller
Journal:  Experientia       Date:  1981-01-15

9.  Complement-dependent, polymorphonuclear neutrophil-mediated cytotoxicity of herpesvirus-infected cells: possible mechanism(s) of cytotoxicity.

Authors:  A S Grewal; L A Babiuk
Journal:  Immunology       Date:  1980-06       Impact factor: 7.397

10.  Effect of cyclic AMP and cyclic GMP on the activity of interferon against herpes simplex virus types 1 and 2, and vesicular stomatitis virus.

Authors:  T L Stanwick; A J Nahmias
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.